As a result, the subsequent activation of the PI3K/AKT signaling pathway boosted aerobic glycolysis (Warburg shift) in sorafenib-resistant cancer cells with defective mitochondria oxidative capacity to protect cell from sorafenib-induced cell apoptosis. The gene discussed is AKT1; the disease is cancer.